Impact of BMI on outcomes in respiratory ECMO: an ELSO registry study.
Marijke PeetermansIpek GulerPhilippe MeerssemanAlexander WilmerJoost WautersBart MeynsAlexander P. J. VlaarAlain CombesGreet HermansPublished in: Intensive care medicine (2022)
Patients with obesity class II or more treated with ECMO for respiratory failure have lower mortality risk and shorter stays, despite increased cardiovascular, device-related, and renal complications. No upper limit of BMI indicating futility of ECMO treatment could be identified. BMI as single parameter should not be a contra-indication for respiratory ECMO.